Compare Ambarella Inc (AMBA) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ambarella Inc vs Quest Diagnostics Inc — how do they compare? Ambarella Inc trades at $84.8 (market cap $3.64B), while Quest Diagnostics Inc trades at $237.5 (market cap $26.21B). The key difference: Quest Diagnostics Inc is far larger — about 7.2× Ambarella Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Ambarella Inc pays none. Which is the better fit depends on your goals.
| AMBA | DGX | |
|---|---|---|
Market Cap | $3.64B | $26.21B |
Sector | Technology | Health |
52-Week High | $95.51 | $238.50 |
52-Week Low | $48.65 | $173.49 |
Enterprise Value | $3.37B | $31.97B |
Dividend Yield | — | 1.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ambarella Inc
Ambarella is a semiconductor company specializing in low-power video compression and computer vision processors. Its chips power AI cameras for security, automotive safety, and robotics applications.
Read more on AMBA →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
